A. John Kanellopoulos, MD
A wide variety of disorders can
overcome the natural defenses of the eye and ocular
adnexa. Our challenge as ophthalmologists is to recognize
and remedythe situations where the eye's defense
systems have failed or overreacted.
Conjunctival Inflammation
The most common cause of red eye
is conjunctival inflammation. Conjunctivitis represents
a wide group of disorders that are characterized
by cellular infiltration and exudation, in addition
to vascular dilation of the conjunctiva. The conjunctiva
is a thick translucent mucous membrane. Its palpebral
portion lies over the posterior portion of the eyelids
and is firmly attached to the tarsal plate, while
the bulbar portion lies loosely over the anterior
globe, with firm adherence at the limbus. The conjunctiva
has an inferior layer of a submucosal substantia
propria that consists of a superficial adenoid portion
containing lymphoid tissue and a deeper fibrous portion
containing mainly connective tissue.
Conjunctivitis is traditionally
classified according to its duration as acute when
under 3 weeks, duration, or chronic when it lasts
more than 3 weeks.
Specific forms of responses of the
conjunctiva, aside from the classic tetrad of ocular
inflammation (pain, warmth, redness, swelling), can
aid in the differential diagnosis of the insulting
agent (bacteria, viruses, allergens). There are six
responses of conjunctiva that will specifically be
addressed.
Conjunctival Discharge
Conjunctival discharge can present
as a serous or mucoid exudate or transudate arising
from the inflamed superfi- cial vessels. In this
case, conjunctival discharge is more representative
of viral origin, toxicity to topically used ocular
medications, or an acute response to an allergic
stimulus. Purulent and thicker consistency discharge
is more common with bacterial infections.
Papillae
Papillae represent edema of the
substantia propria of the conjunctiva, that is densely
adherent to the tarsal plate. Therefore, the portion
of the substantia propria that lies between the fibrous
attachments of the conjunctiva and the tarsal plate
swells and forms an array of "bumps" to the palpebral
conjunctival portion. Tarsal papillae are not specific
signs of conjunctivitis, they can be mild when moderate
conjunctiva inflammation is present, or they can
be marked when severe or long-lasting conjunctival
inflammation is present. Chronic conjunctivitis can
cause the septae between individual papillae to break
loose and resolve, it can also cause the papillary
hypertrophy to become more confluent, generating
larger papillae. Giant papillary conjunctivitis is
usually a response to foreign bodies (contact lenses
and suture materials), vernal conjunctivitis (a seasonal
hypersensitivity reaction in young adults), and atrophy.
Follicles
Follicles represent whitish or yellow
discrete round lesions of the conjunctiva produced
by a specific response. Unlike papillae, the central
portion of the follicle is avascular, with blood
vessels sweeping up over the convexity from the base.
They are most readily appreciated in the upper tarsal
conjunctiva and the lower cul-de-sac. However, they
can also be seen in the limbus. They represent normal
findings when seen in the temporal tarsus in young
adults. FoUicular conjunctivitis is usually diagnostically
divided into acute foUicular conjunctivitis that
can be caused by adenoviral conjunctivitis or viruses
such as measles, vaccinia, coxsackieviruses, herpes,
and enterovirus. Chronic follicular conjunctivitis
is usually caused by chlamydial infections (inclusion
conjunctivitis), toxic reactions, molluscum contagiosum,
Moraxella, Lyme disease, toxic conjunctivitis, and
foUiculosis
Table 1: Etiology of
conjunctivitis differentiated based on typical
clinical findings |
| Papillary conjunctivitis - The cause
is usually allergic or bacterial. |
| Follicular conjunctivitis - The cause
is usually adenoviral. Other common causes
are herpes simplex, drug-toxicity, molluscum,
acute hemorrhage conjunctivitis, and chlamydia. |
| Conjunctivitis membrane/pseudomembrane -
Severe viral or bacterial cause, Stevens-Johnson
syndrome, and chemical injuries. |
| Conjunctival granulomas - The cause
is usually cat-scratch disease and sarcoid. |
Pseudomembranes and True-Membranes
When inflammatory exudation intermixes
with inflammatory cells and other infectious or allergic
cellular debris, it may precipitate over the conjunctival
surface as a uniform membra- nous sheet. This represents
the membrane or pseudomembrane conjunctival formation.
The difference between the two is purely the underlying
hemorrhage when removal is present with true-membranes
representing more serious, more adherent precipitation
of inflammatory debris. Usual causes of membranous
or pseudomembranous conjunctivitis are severe viral
or bacterial conjunctivitis, such as epidemic keratoconjunctivitis
or streptococcal infections, Stevens-Johnson syndrome,
and chemical burns.
Cicatridal Changes and Granuloma
Cicatricial changes in the conjunctiva
occur only when there is destruction ofstromal tissue.
It follows the sequence of inflammation and linear
fibrosis in the conjunctivia fornix, resulting in
foreshortening of the fornix and possible symblepharon
formation along with cicatricial entropion and trichiasis.
Enlarged Preauricular Lymph
Node
The final clinical finding specifically
related to conjunctival inflammation is the enlarged
preauricular lymph node palpable to physical examination
with or without tenderness. Usually the presence
of a preauricular lymph node is indicative of viral,
chlamydial, gonococcal, or allergic etiology.
Table 2: Normal flora
of the eye surface |
Organism |
Normal conjunctiva/eyelid |
Staphylococcus epidermidis |
+++ |
Staphylococcus aureus |
++ |
Diphtheroids |
++ |
Propionibacterium acnes |
++ |
Streptococcus species |
+ |
Haemophilus influenza |
+/- |
Moraxella |
+/- |
Yeasts |
- |
Filamentous fungi |
+/- |
Demodex |
+/- |
Treatment
Obviously, the principal agents
in the treatment of conjunctivitis are topical antimicrobials
and anti-inflammatory agents. Antiviral therapy has
evolved over the years and is currently available
for herpes viruses. In the United States, three types
of antivirals are currently available topically for
herpetic conjunctivitis and keratitis - vidarabine,
idoxurridine, and trifliridine. They are effective
in managing herpetic keratoconjunctivitis, although
they can cause significant toxic reactions, such
as superficial punctate keratitis, corneal ulceration
and chronic follicular conjunctivitis.
A medicine that has shown less topical
toxicity and good antiviral efficacy is the topical
formulation of acyclovir in 3% ointment. It is not
commercially available in the United States. There
has been promising development of an efficacious
topical antiviral against adenoviruses and specifically
the serotypes 8 and 19, which cause epidemic keratoconjunctivitis.
The formulation is expected to be commercially available
in the United States in the near future.
The antibacterial management agents
effective against chlamydia are mainly sulfonamides
and systemic medications (tetracycline, doxycycline,
and minocycline). Erythromycin is used in the treatment
of neonatal chlamydia eye disease. Agents used against
gramnegative rods are topical aminoglycosides, such
as gentamicin and tobramycin having good efficacy
against such microbes. However, they can be responsible
for some allergic and toxic reactions of the eye
surface. Agents mainly effective against gram-positive
cocci are bacitracin, cephalosporins and vancomycin.
For purposes of wide spectrum activity against both
gram-positive and gram-negative organisms, fluoroquinolones
(ofloxacin and ciprofloxacin) can be used as monotherapy
for the management of bacterial conjunctivitis especially
when suspicion of corneal involvement is eminent.
In the management of allergic conjunctivitis,
topical vasoconstructive agents along with topical
antihistamines and mast cell stabilizers, and topical
nonsteroidal anti-inflammatory agents are commonly
employed. In severe allergic reactions, more potent
anti-inflammatory agents such as corticosteroids
can be used. Cyclosporine A, a potent T cell immunomodulator
has been employed in special topical formulations
in treating specific types of allergic conjunctivitis
where helper T cell suppression and increased tear
production are of benefit.
References
- Stem ME, Beuerman RW, Fox Rl et al. The pathology
of dry eye: The interaction between the ocular
surface and lacrimal glands. Cornea. 1998;17:584-589.
- Borel JF, Baumann G, Chapman let al. In vivo
Pharmacological Effects of Cyclosporin and Some
Analogues. PharmacoL 1996;35:115-246.
(Source: Therapeutic Update, 1999
Vol. 2 No 2)
|